Consistency across multi-omics layers in a drug-perturbed gut microbial community
暂无分享,去创建一个
Thomas S. B. Schmidt | Philipp E. Geyer | P. Bork | R. Hercog | Michael Kuhn | K. Patil | Suguru Nishijima | Anja Telzerow | Renato J Alves | S. Wuyts | Ece Kartal | Marja Driessen | D. Sévin | T. S. Schmidt | Sonja Blasche | Peter V. Treit | M. Mann | Johannes B. Müller | Maria Zimmermann-Kogadeeva | Lisa Maier | Athanasios Typas | Sarela Garcia Santamarina | Tobias Wenzel | Peer Bork | Matthias Mann | Suguru Nishijima | Sarela Garcia Santamarina | T. S. B. Schmidt | Daniel C. Sevin | Kiran R. Patil
[1] K. Patil,et al. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota , 2022, Nature Reviews Microbiology.
[2] Philipp C. Münch,et al. In vitro interaction network of a synthetic gut bacterial community , 2021, The ISME Journal.
[3] Ana Rita Brochado,et al. Bioaccumulation of therapeutic drugs by human gut bacteria , 2021, Nature.
[4] Peter Bowden,et al. The Plasma Proteome , 2021 .
[5] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[6] William W. Van Treuren,et al. A metabolomics pipeline for the mechanistic interrogation of the gut microbiome , 2021, Nature.
[7] N. Neff,et al. Systematic dissection of a complex gut bacterial community , 2021, bioRxiv.
[8] M. V. van Loosdrecht,et al. Database-independent de novo metaproteomics of complex microbial communities. , 2021, Cell systems.
[9] K. Patil,et al. Towards a mechanistic understanding of reciprocal drug–microbiome interactions , 2021, Molecular systems biology.
[10] Exene Erin Anderson,et al. Unravelling the collateral damage of antibiotics on gut bacteria , 2021, Nature.
[11] M. Savitski,et al. The functional proteome landscape of Escherichia coli , 2020, Nature.
[12] P. Manghi,et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3 , 2020, bioRxiv.
[13] H. Taguchi,et al. Escherichia coli small heat shock protein IbpA is an aggregation‐sensor that self‐regulates its own expression at posttranscriptional levels , 2020, Molecular microbiology.
[14] Robert L. Marshall,et al. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump , 2020, mBio.
[15] Bahar Javdan,et al. Personalized Mapping of Drug Metabolism by the Human Gut Microbiome , 2020, Cell.
[16] Jingyuan Fu,et al. Interaction between drugs and the gut microbiome , 2020, Gut.
[17] Luis Pedro Coelho,et al. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis , 2020, Nature.
[18] H. Taguchi,et al. Escherichia coli small heat shock protein IbpA is an aggregation-sensor that self-regulates its own expression at a translational level , 2020, bioRxiv.
[19] Se Jin Song,et al. Consumption of Fermented Foods Is Associated with Systematic Differences in the Gut Microbiome and Metabolome , 2020, mSystems.
[20] A. Kurilshikov,et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota , 2020, Nature Communications.
[21] Donovan H Parks,et al. GTDB-Tk: a toolkit to classify genomes with the Genome Taxonomy Database , 2019, Bioinform..
[22] Luis Pedro Coelho,et al. Gene Expression Changes and Community Turnover Differentially Shape the Global Ocean Metatranscriptome , 2019, Cell.
[23] L. Piddock,et al. Do phenothiazines possess antimicrobial and efflux inhibitory properties? , 2019, FEMS microbiology reviews.
[24] B. Henrissat,et al. Interspecies Competition Impacts Targeted Manipulation of Human Gut Bacteria by Fiber-Derived Glycans , 2019, Cell.
[25] K. Bryson,et al. Host-Microbe-Drug-Nutrient Screen Identifies Bacterial Effectors of Metformin Therapy , 2019, Cell.
[26] A. Goodman,et al. Mapping human microbiome drug metabolism by gut bacteria and their genes , 2019, Nature.
[27] Jae Kyoung Kim,et al. Bayesian inference of distributed time delay in transcriptional and translational regulation , 2019, bioRxiv.
[28] Xu Zhang,et al. Perspective and Guidelines for Metaproteomics in Microbiome Studies. , 2019, Journal of proteome research.
[29] E. Yamashita,et al. Structures of the wild-type MexAB–OprM tripartite pump reveal its complex formation and drug efflux mechanism , 2019, Nature Communications.
[30] Luis Pedro Coelho,et al. Microbial abundance, activity and population genomic profiling with mOTUs2 , 2019, Nature Communications.
[31] Robert D. Finn,et al. A new genomic blueprint of the human gut microbiota , 2019, Nature.
[32] Michael Zimmermann,et al. Separating host and microbiome contributions to drug pharmacokinetics and toxicity , 2019, Science.
[33] E. Korzeniewska,et al. The emergence of antimicrobial resistance in environmental strains of the Bacteroides fragilis group. , 2019, Environment international.
[34] T. Dinan,et al. Schizophrenia and the microbiome: Time to focus on the impact of antipsychotic treatment on the gut microbiota , 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[35] A. Phillippy,et al. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries , 2018, Nature Communications.
[36] Donovan H. Parks,et al. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life , 2018, Nature Biotechnology.
[37] Tiphaine Martin,et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort , 2018, Nature Communications.
[38] Patrice D Cani. Human gut microbiome: hopes, threats and promises , 2018, Gut.
[39] Amalio Telenti,et al. The fecal metabolome as a functional readout of the gut microbiome , 2018, Nature Genetics.
[40] R. Ghotaslou,et al. The role of efflux pumps in Bacteroides fragilis resistance to antibiotics. , 2018, Microbiological research.
[41] Peer Bork,et al. Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.
[42] P. Bork,et al. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies , 2018, Nature Microbiology.
[43] P. Bork,et al. The Human Gut Microbiome: From Association to Modulation , 2018, Cell.
[44] Paul Wilmes,et al. Human Gut Microbiome: Function Matters. , 2017, Trends in microbiology.
[45] Astrid Gall,et al. Ensembl 2018 , 2017, Nucleic Acids Res..
[46] David S. Wishart,et al. HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..
[47] Mikhail Tikhonov,et al. Emergent simplicity in microbial community assembly , 2017, Science.
[48] E. Groisman,et al. Navigating the Gut Buffet: Control of Polysaccharide Utilization in Bacteroides spp. , 2017, Trends in microbiology.
[49] M. Strous,et al. Assessing species biomass contributions in microbial communities via metaproteomics , 2017, Nature Communications.
[50] Arthur Brady,et al. Strains, functions and dynamics in the expanded Human Microbiome Project , 2017, Nature.
[51] Christian von Mering,et al. MAPseq: highly efficient k-mer search with confidence estimates, for rRNA sequence analysis , 2017, Bioinform..
[52] David Torrents,et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug , 2017, Nature Medicine.
[53] P. Meinicke,et al. How to normalize metatranscriptomic count data for differential expression analysis , 2017, bioRxiv.
[54] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[55] Jeremy K Nicholson,et al. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. , 2017, Translational research : the journal of laboratory and clinical medicine.
[56] Luis Pedro Coelho,et al. Fast Genome-Wide Functional Annotation through Orthology Assignment by eggNOG-Mapper , 2016, bioRxiv.
[57] Judith B. Zaugg,et al. Data-driven hypothesis weighting increases detection power in genome-scale multiple testing , 2016, Nature Methods.
[58] Paul J. McMurdie,et al. DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.
[59] J. Jansson,et al. A multi-omic future for microbiome studies , 2016, Nature Microbiology.
[60] Peter J. Turnbaugh,et al. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism , 2016, Nature Reviews Microbiology.
[61] P. Bork,et al. ETE 3: Reconstruction, Analysis, and Visualization of Phylogenomic Data , 2016, Molecular biology and evolution.
[62] Brian D. Ondov,et al. Mash: fast genome and metagenome distance estimation using MinHash , 2015, Genome Biology.
[63] Rob Knight,et al. Analysis of composition of microbiomes: a novel method for studying microbial composition , 2015, Microbial ecology in health and disease.
[64] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[65] Torsten Seemann,et al. Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..
[66] Karen De Roy,et al. Synthetic microbial ecosystems: an exciting tool to understand and apply microbial communities. , 2014, Environmental microbiology.
[67] M. Mann,et al. Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells , 2014, Nature Methods.
[68] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[69] Hélène Touzet,et al. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data , 2012, Bioinform..
[70] Matthias Mann,et al. SprayQc: a real-time LC-MS/MS quality monitoring system to maximize uptime using off the shelf components. , 2012, Journal of proteome research.
[71] H. Wexler. Pump it up: occurrence and regulation of multi-drug efflux pumps in Bacteroides fragilis. , 2012, Anaerobe.
[72] M. Blaser,et al. The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.
[73] C. Koch. Statin therapy. , 2012, Current pharmaceutical design.
[74] Sean R. Eddy,et al. Accelerated Profile HMM Searches , 2011, PLoS Comput. Biol..
[75] U. Sauer,et al. Regulation and control of metabolic fluxes in microbes. , 2011, Current opinion in biotechnology.
[76] J. Gordon,et al. Human nutrition, the gut microbiome and the immune system , 2011, Nature.
[77] Mariam R. Rizkallah,et al. Expert Review : The Human Microbiome Project , Personalized Medicine , and the Birth of Pharmacomicrobiomics , 2010 .
[78] William A. Walters,et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample , 2010, Proceedings of the National Academy of Sciences.
[79] E. Virginia Armbrust,et al. pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree , 2010, BMC Bioinformatics.
[80] Paramvir S. Dehal,et al. FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.
[81] Miriam L. Land,et al. Trace: Tennessee Research and Creative Exchange Prodigal: Prokaryotic Gene Recognition and Translation Initiation Site Identification Recommended Citation Prodigal: Prokaryotic Gene Recognition and Translation Initiation Site Identification , 2022 .
[82] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[83] C. Bailey,et al. Metformin and the intestine , 2008, Diabetologia.
[84] Hannah M. Wexler,et al. Bacteroides: the Good, the Bad, and the Nitty-Gritty , 2007, Clinical Microbiology Reviews.
[85] S. Levy,et al. Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.
[86] K. Das,et al. Aggregation of insulin by chlorpromazine. , 2001, Biochemical pharmacology.
[87] T. Imai. [Glutamate dehydrogenase]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.
[88] A. Grossman,et al. Regulation of the Heat-Shock Response in Escherichia coli , 1987 .
[89] J. Kristiansen,et al. The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.